ClinicalTrials.Veeva

Menu

Trial on Use of Coloshield in Transanal and Anal Surgery

D

Daniel Steinemann, MD

Status

Unknown

Conditions

Anal Fissure
Rectal Polyp
Fistula-in-ano
Hemorrhoids
Rectal Adenoma

Treatments

Device: Coloshield
Other: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT02579330
2015-341

Details and patient eligibility

About

In various transanal and anal procedures it is desirable to clean the operating field from stool contamination. Thus mechanical bowel preparation is not well tolerated by patients. Enema does not provide sufficient effect. By the use of Coloshield a rectal washout might be performed and enable a clean operating field. In this randomized controlled trial the macroscopic contamination of the rectum with and without Coloshield is compared using the Boston Bowel Preparation Score (0-3).

Enrollment

22 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing surgery for Fistula-in-ano, transanal resection of rectal Polyp or Adenoma, haemorrhoids or anal fissure.

Exclusion criteria

  • Age <18 years
  • inability to give informed consent
  • pregnancy
  • missing informed consent
  • emergency Operation (<24hours of diagnosis and admission at emergency room)
  • rectal strictures or Stenosis
  • status post rectal resection or pelvic Radiation therapy
  • inflammatory bowel disease with inclusion of the rectum
  • need for mechanical bowel preparation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

22 participants in 2 patient groups

Coloshield Group
Experimental group
Description:
In the Intervention group the Coloshield Device (double balloon system) will be introduced at the beginning of surgery followed by a washout of the rectum with 500ml of saline solution. The grade of macroscopic contamination will be assessed.
Treatment:
Device: Coloshield
Other: Control
Control Group
Sham Comparator group
Description:
In the control Group the grade of macroscopic contamination will be assessed after rectal washout with 500ml of saline solution.
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Central trial contact

Daniel C Steinemann, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems